secwatch.observer — SEC 8-K summary
======================================

Issuer:     Novo Integrated Sciences, Inc. (—)
CIK:        0001138978
Form:       8-K
Filed at:   2024-11-14T23:59:59+00:00
Accession:  0001493152-24-045968
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Novo Integrated Sciences CEO Robert Mattacchione resigns effective Feb 5, 2025; remains Chairman
--------------------------------------------------------------------------------

- CEO Robert Mattacchione resigned effective February 5, 2025, following a 90-day transition period.
- Resignation was not due to any disagreement with the company on operations, policies, or practices.
- He will continue as Chairman of the Board and Chairman of Novo Healthnet Limited, a wholly owned subsidiary.
- He remains a director nominee for election at the annual meeting on November 22, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1138978/000149315224045968/0001493152-24-045968-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1138978/000149315224045968/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-045968

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer